In the tu'st study to examine direct nicotinic augmentation of central cholinergic functioning in Alzheimer's disease, six patients were studied in an intensive pilot study with three doses (0.125, 0.25, and 0.5 I~g/kg/min) of intravenous nicotine and placebo. Cognitive tests showed a decrease in in
Ethyl-EPA in Alzheimer's disease—a pilot study
✍ Scribed by Paul F. Boston; Amanda Bennett; David F. Horrobin; Crispin N. Bennett
- Book ID
- 116838314
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 186 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0952-3278
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The purpose of this study was to determine whether dyscalculia is present in the early stages of Alzheimer's disease (AD) and if it is associated with a characteristic neuropsychological pattern. We examined 28 probable AD patients with scores of 18 or greater on the Mini-Mental State Examination (M
The pharmacological management of behavioural symptoms in Alzheimer's disease is limited by the dearth of effective agents in this area. The purpose of this study was to determine whether trazodone or buspirone are helpful in the treatment of behavioural disturbance in AD. Ten patients meeting NINCD